AutoNorm™ adaptive amplification technology to lower throughput sequencing workflows. The system monitors each well in real time and stops amplification individually at a user defined endpoint, ...
StockStory.org on MSN
ILMN Q1 deep dive: Clinical sequencing fuels growth as NovaSeq X demand surges
Genomics company Illumina (NASDAQ:ILMN) reported Q1 CY2026 results , with sales up 4.8% year on year to $1.09 billion. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results